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Because the effects ?F :hanging technology in ,?ercutaneous 
transluminal coronary q$oplasty, increased operator 
experience and use of the procedure in patierts with 
extensive disease are unknown in regard to compliration 
patterns, the mitial 1977-1981 cohort ;rnd the recent 198§- 
1986 cohort of the National Hear!, Lung, and 81o~J 
Institute Percutaneous Transluminul Coronary bgioplasty 
Registry wereanalyzed with respect to complications. Com- 
pared with the initial Lohort of 1.855 patients. the 1,801 
new cohort patients were older and had an increased 
prevalence of muitivessel coronary artery disease, de- 
pressed left ventricular function and prior infarction. 
Overall complication rates in the recent cohort were either 
unchanged or decreased from the rates in the i&da! c&ort 
despite a higher risk patient population. The most significant 
decreases were in the incidence of coronary spasm (p < 0.001 I 
and the need for emergency coronary bypass surgery (p = 
_-- 
0.01). Qrerzd! in-hospital mortalitp was low but ~2s Dean- 
dent on the extent of ~4 di..~as~---O.2% for sing:e se4 
disease, O.Qrb f0r double v-8 diseas? and 2.2% f0r triple 
Bessel disease tp < O&O1 for linear trend). Acute cotonarp 
complications of branch r~chlsion, &w&m or abrupt clo- 
sure were as55ciated with increased s&es of death, r.onfata! 
infarction Or rK-4 for ePnergeIq srrrg!?ry. Fast0r-5 SR0wint: a 
multi+ariate aW2&tion with increased rnortiity included a 
history of con@ive heart failure ip L O.(fo% ). age -65 years 
(p < 0.01 f. triple vessel or left main coronary artery diwace ip 
,i 0.05), female gender (p < &OS) and WY +r..~t an@na. 
These data sipport the concept that, although coronary 
angioplasty is used in asl increased number of patie,lt\ with 
more extensive disease, its etTecti%eness has improved: !I e 
procedure, however, has an associated complication rate 
that, although small, is not negligible. 
(J Am Coil Cardio: 1988;12:l1451-55) 
Since !he Intiodnctlon of per~ot~~o~!i ~ran\h;mnM COfonXy 
dng:opla\t> III i 977 ( I .2.!. clinical and anglographic indlcatloni 
for the procedttre have evolved and expanded rapidly. Wl~h 
rhe substantial advance5 in technology and funher refine- 
ment\ In rht: whnique. one mqht expccr the current inci- 
iirilct of ;iswziaied complications to be lower than thdi 
~re~rou4y observed !3-9). Ahernallvciy. recem dafa \uggc-J 
rhar ;oronar)- angroplasty ts being performed In higher rl\k 
patlenti \\ho <ire older and have more complex. difi&c 4 
tiistbl ~IYJ,I~,C ,md poorer left venrricular f~nc~ior (IO--i-l) in 
~he,e p,~~cnt~. the poientldl for and m;rnlfAai!ons ofcum$- 
071F.lW17 S#h 'I) 
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cations IIII+ hc different from those in the population dc- 
scribed in [he early reports from the National Heart. Lung, 
and Blood Irthtitute Percutaneous Transluminal Coronary 
Angioplasty Registry (3.4,15,16). 
The objcctivc of this report is lo characterize in-hospital 
complications in the cohort of patients enrolled in the 
Registry from 1985-1986 and IO contrast the complication 
rates with those of patients in the initial Registry cohort who 
had angiopiasty from 1977-1981. 
Statistical methods. Complication rates between the two 
,ohorts were compared by calculation of &i-square sratis- 
tics. The chi-square test for linear trend was used to compare 
complication rates in the new cohort according !a the 
number of diseased vessels and the number of vessels in 
which dilation was attempted. Backward stepwise logistic 
regression was used to develop models to evaluate the 
association between specific risk factors and fatal outcome. 
Both baseline variables and complication data were used in 
the construction of the final model. 
Results 
Basetine clinical characteristics. As discussed, I, 155 pa- 
tients formed the initial 1977-1981 cohort and 1.801 patients 
were in the new 1985-1986 cohort. As reported elsewhere 
(14), the differences in baseline characteristics between the 
two cohorts were statistically significant; the new cohort had 
an increased proportion of patients with prior coronary 
artery bypass grafting (p < O.Ol), prior infarction (p < 
O.OOl), multivessel disease (p < 0.001) and depressed left 
ventricular function (p < 0.001). In addition, multiple lesions 
were dilated in 40% of the new cohort but in only 9% of the 
initial cohort (p < 0.001). 
Success rates. Despite the fact that the new cohort in- 
cluded patients with more extensive and severe disease, 
success rates improved significantly (p c 0.001): 91% of 
Registry. Because the initial group excluded patients under- 
going dilation during acute myocardial infarction, the 293 
patients in the new Registry who had angioplasty during 
acute myocardial infarction were likewise excluded from the 
analysis. The remaining I.801 patients were included in the 
analyses that fellow. 
reopened to new cases with the goals of confirming and 
documenting changes in angioplasty results and strategy. 
Fifteen centers corresponding to the 14 sites (the investiga- 
tars at on,: 1977-1981 center had formed two separate study 
siles by 1985-1986) of the early Registry discussed before 
contributed data on all patients who had their first angio- 
plastp between August 1985 and May 1986. Of the 19851986 
Registry patients, 80% had their angioplasty performed by 
physicians who participated in the 1977-1981 Registry. A 
total of 2.094 first procedures were entered into the new 
Definitions. Successful dilation of a lesion was defined as 
a Z!O% improvement of the luminal diameter stenosis 
(vistizl estimate). Clinical success was defined as successful 
dilation of all lesions in which angioplasty was attempted 
withcut in-hospital death, infarction or coronary bypass 
nificant difference. The most significant decrease was in the 
incidence of coronary spasm from 5.0% in the initial cohort 
to 1.3% in the new cohort (p < 0.001). The incidence of 
emergency coronary artery bypass grafting also decreased 
significantly from 5.8 to 3.5% (p c 0.01). The rate of the 
combined end point of death, myocardial infarction or 
emergency coronary artery bypass grafting declined from 8.8 
to 7.2%. a nonsignificant difference. 
patients in the new cohort had improvement of ~20% in at 
least one segment dilated, and 85% had at least one segment 
successfully dilated and no in-hospital death, myocardial 
infarction or coronary artery bypass grafting. Seventy-eight 
percent of patients had all attempted segments successfully 
dilated without death, infarction or coronary artery surgery. 
Differences in complication rates between the two cohorts 
(Table 1). The incidence rates for each complication cate- 
gory, except occlusion, were lower in the new cohort. The 
incidence of occlusion increased from 4.5 to 4.9%, a nonsig- 
Relation between major complications and extent of initial 
coronary artery disease (Table 2). in-hospital mortality in the 
new cohort increased with the number of diseased vesseIs: 
operation. Myocardihl infarction was diagnosed when the 0.2% with single vessel disease, 0.9% with double vessel 
serum creatine kinase value increased IO 21.5 times normal, disease and 2.2% with triple vessel disease (p < O.OOlL The 
with MB h-action present and new Q waves present after in-hospital mortality rate for patients with left main coronary 
angioplasty. Coronary dissection was defined as an intralu- artery disease was even higher. There were nonsignificant 
minal linear filling 
during dKation. 
defect or a persistent parietal radiopacity trends toward higher rates if nonfatal myocardial infarction 
and emergency coronary artery bypass grafting in patients 
Table I. Complication\ of Coronary Angiopl:l\ty in the Two 
Pihlt Cohorts 
Coronary cpavn 
Coronary 0cclukWl 
Coronary dkecliun 
Prolonged angina 
Death 
Nollfadral hil 
Emergency CABG 
Death. MI or 
emergency CABG 7.2 Ii12 8.X ‘!S _ . 
CABG = coronary artery bypa\\ gnlfting. MI = m)ocadiel mfdntion. 
NS = no? ~ignificanl. 
with more severe disease. ‘fhe incidence of the combined 
outcome of death, myocardial infarction or emergency cor- 
onary artery bypass grafting was 5.5. 8.1 and 9.3% for 
patients with single, double and triple vessel disease, respec- 
tively (p < 0.05 for linear trend). Evidence for an increased 
complication raie with more severe vessel disease was also 
found for occlusion (p < 0.01) and prolonged angina (p < 
0.05). The complications of spasm, dissection. branch occlu- 
sion. ventricular fibrillation and abrupt closure had incidence 
rates independent of the extent of vessel disease. 
Figure I. Inkrrel;tlion of acute coronary evenls (myucardkll inkrc- 
tiGn j4111. ooron,lry occlusion and coronary dk\ci’kon) &kr core- 
nq .~qtopl~~~ry IPTC.4) in the 19X5-1986 cohon of I .X01 patents. 
Coinpiic rrtirms wrc trho m.sr.s.si~I rrc~~mli~i~ to rirc I~PI- 
her of ~~r.s.st~ls iti wlric~A ~!ildorr IWS tmwrpred. The fre- 
quency of nonfatal infarction increased with an increased 
number of vc\sels attempted (4. I, 4.9 and 7.3% for attempts 
al one. tbwo and three vessels. respectively), but the trend 
was not sqilicant. The incidence of branch occlusion also 
tended to increase with an increased number of vessels 
attsFJted (I .‘I. 2.9 and 3.6% for one. two and three vescels. 
rerpectlveiy). although the trend was not significant. 
Alihough the overall incidence of any c,pecific comptica- 
lion was low. complications tended to occur in clusters. One 
of the slrongc51 interrelations was observed among infarc- 
tion. coronary artery occlusion and coronary dissection (Fig. 
1). Of the 8X patients with occlusion. 17 (19%) also had 
dkection and 35 (40%) subsequently had infarclion docu- 
mented. 
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Figure 2. Intcnrlation of maior com~licaliunr (death. mvocnrdial 
irkarclion IMII. cmcrgcnc; coronky artery hypass~ grafting 
[CABG]laf~cr coron:~ryan~iopla~fy (PTCA1 in the 19&S-19Rhcohort 
or 1.8fll paflcnl\. 
0rurf-y NI’IcI:\’ lqms ~rufrirr~ irrrd idwspirtrl tlctrlh wrc dso 
~NW c#rrrc~f (Fig. 2). Of 85 patients who had procedure- 
related myocardial infarction . 28 (33%) also required emer- 
gcnc~ coronary arlcry bypm txrafting. Seven (8%) of these 
KS patients suhscquenrly died in lhe hospital. 
Si,qrr$iw~l st~qrri~lr~c qfifw re.srrhd fiwi twitch c~~~tti~r~ 
c.o,rlpli(,Nfir,rts (Tdh 3). Procedure-related ventricular fibril- 
lation. although occurring in only 21 patients. was associated 
with a 14% mortality and a 48% incidence of nonfatal 
infarction. The other complications were associated with 
lower rates of subsequent morlalily. but they were still 
associated with substantiallv higher rates of subseauent 
death, nonfalal myocardjal irk&on and subsequent emcr- 
gcncy coronary artery bypau grafting than those in the 
patient popuiation as a whole. 
Effect of complications 011 duration of hospital stay {Table 
4). For the 1.398 patients in the new cohort without any 
complica!ions (all of whom, by definilion. left the hospital 
alive), the median duralion of hospitalization was 2 days. In 
contrast. for patienrs who had one or more complications 
and left the hospital alive. the median duration was 5 days. 
As expected. the specific type of complication affected the 
duration of in-hospital stay, which ranged from a median of 
3 days for patients with coronary spasm to IO days for 
Tabk 3. Acule Coronary Evcnt~ and Their Sequclae After 
Coronary Angioplasty in the IYXS-1986 Cohort (I .X01 p;tGeats) 
NWlfillUl Emsraencv 
Ventrictklr fibrillation 
Proknged ilnf~na 
Tahlc 4. ElTcct of Complications on Durafion of Hospi!al Slay for 
Survivor\ o~Corormry Angiuplasly in 198.5-1986 Cohort 
(I.XOI palients) 
NOttC 1,398 77.6 
Any 4113 22.4 
Ml 85 4.7 
MI. no emcrgcncy CABG 57 3 2 
MI. emergency CABG 18 I .6 
Emergency CABG 63 3.5 
Coronary occlusion 88 4.9 
Abrupt cl<~sttre 39 2.2 
Verdricular fibrillation 21 1.2 
Curonary spasm 23 I.3 
Coronary ditsection X6 4.x 
Prolonged angina R4 4.7 
Abbrevintionc as in Table I. 
Survivors 
(daysI 
G) Median Range 
loo.0 2 0 to 49 
95.5 5 1 l05n 
Y1.H 8 I IO50 
93.0 7 I IO39 
89.3 II 7 IO 50 
92.1 II 7 lo 50 
95.5 8 1 to50 
94.9 IO 2 to 30 
85.7 8 I to 39 
IIHl.0 3 I to I8 
98.8 7 I to21 
964 6 I to 20 
surviving patients with abrupt closure and I I days for 
patients who underwent emergency coronary artery bypass 
grafting. 
Risk factors associated wlh increased in-hospital mortality 
(Table 5). In the new cohort, factors that showed a multi- 
variate association with in-hospital mortality included the 
baseline variables of history of congestive heart failure. age 
265 years. triple vessel or left main coronary artery disease, 
female gender and new onset angina. Two procedural com- 
plications, myocardial infarction and ventricular fibrillation, 
also showed a very strong association with mortality* 
The relation between the combined end point of death, 
myocardial infarction or emergency coronary artery bypass 
grafting and the number of diseased vessels and the number 
of vessels with attempted dilation was assessed. Patients 
Table 5. Predictors of In-Hospital Mortality After Coronary 
Angioplasty (multivariak IogisIic model) in 1985-1986 Cohort 
Female gender 
Age 265 years 
Hirwry or cong~esr~vc 
heati failure 
New onset angina 
Double vewf &ease 
vrrw smgle 
Triple or LM ~cswI 
diseil\e venue $ingle 
Ml (a complicationl 
Vcntriculer tibrillalion 
(a\ complication) 
Odds 
Ralio 
3.22 
9.54 
Y.46 
3.10 
2.78 
7.65 
7.9h 
8.60 
Slandardired 
Coetlkienl* 
I.99 (p < 0.051 
3.14 (p < O.O[l 
3.75 (p < 0.001) 
1.95 
I.13 
2.51 (p < 0.05) 
3.17 (p < O.IlI) 
Xl (p < O.US) 
‘Mcawre~ ~latdcd wgnificance of odds ralw LM = left muin curvnary 
artery: other abbrcviation~ a~ in Table I. 
who had a similar number of vessels with discax and 
atlempted dilation had a low combined event rate of approu- 
imately 6%. Patients who had more diseased vessels thaiI 
vessels with attempted dilation had a slightly higher rate of 
AC combined end point; for erample, the inctdence of the 
combined end point of death, myocardial infarction or 
emergency coronary artery bypass grafting was 10.3% in 
patients with three diseased vessels in whom only one ves,el 
was attempted, but it was 5.4% in patrents with one diseased 
vessel in whom that single lesion was dilated. 
Discussion 
coronary artery bypass grafting. Despite these differences in 
Complication rates ifi 1385-1986 versus 19779-1988 cohorts. 
The 1985-1986 Registry documents the in-ho?pitdl results 
recently attained with coronary angioplasty f 14). The 19X5- 
baseline characteristics, no significant increases in compli- 
1984 cohort of patients might have been expected to have a 
potentially higher risk for comphcations compared with the 
cation rates occurred, and 91% of patients had ~20% im- 
initial cohort because of their higher prevalerice of certain 
risk factors, including older age, abnormal teft ventricular 
function. multivessel disease. prior infarction and prior 
may he ,I~wcI;~~c~ with more \evere adverse hemdynamic 
c0nWqucncc'i In a patlent will; more extensive triple vc~cl 
disease than in a patient with a single isolated stenosis. 
most severe stenosis was usually approached initially and 
other lesions wert; attempted only if the first lesion was 
Although the in-‘J F ~:‘e .re of some complicalions wa\ fc- 
latcd to the extent of coronary artery disease. no significant 
successfully treated. This approach to the angioplasty pro- 
az\uLldtions were found between complication rates and the 
number of vessels subjected to dilation. The incidences of 
nonfatal Infarction. branch occlusion and abrupt closure 
iended to increase with the number of attempts. Cross- 
claMicat~on of the combined end pomt of death, myocardial 
infarctil;n or emergency coronary artery bypass grafting by 
the number of diseased vessels and the number of vesicle 
wrth attempted dilation was also performed. The patients 
who had fewer vessels with attempted dilation than vessels 
with disease (that Is. one or two vessels with attempted 
dilation in a patient with triple vessel disease or one attempt 
in a patient with double vessel disease) had slightly higher 
rates of this combined end point. This finding could be 
artifactuat because the complications could be the reason for 
the le\\ aggressive procedure. Presumably, for patients in 
whom dilation of more than one vessel was attempted. the 
provement in at least one lesion in which dilation was 
attempted. 
In fact, the incidence of emergency bypass grafting and 
coronary spasm declined significantly, and the occurrence of 
death, nonfatal infarction, coronary occIusion. coronary 
dissection and prolonged angina remained essentialJy un- 
changed. The incidence of the miljor complication defined as 
death, infarction or emergency coronary artery bypass graft- 
ing decreased from 8.8 to 7.2%. 
Subgroup of patients at higher risk for complications. 
Although complication rates decreased or remained un- 
changed within the 1985-1986 cohort. selected subsets of 
patients showed increased potential for certain complica- 
tions. In particular, patients with more extensive coronary 
artery disease bad significantly higher rates of some major 
complications. The patients with single and double vessel 
disease had a ro!atively low mortality rate (0.2% and 0.9%. 
respectively),‘whereas those with triple vessel or left main 
coronary artery disease had a mortality rate of 2.2% and 
8.1%, respectively. The incidence of the combined compli- 
cation of death, infarction or emergency bypass grafting 
increased from 5.5% in patients with single vessel disease to 
8.1% in patients with double and 9.3% in those with tnple 
vessel disease. Similar significant trends were noted for the 
complications of occlusion and prolonged angina. This pos- 
itive association is consistent with the findings of other\ 
(15,16). It is also not surprising given the fact that. after a 
target vessel is reached, the results of balloon inffation 
depend on local arterial/batlocn relations. which often can- 
not be predicted. If a local arterial complication develops. it 
cedure may account for the lack of association between 
complication rates and number of vessels with attempted 
dilation. 
Associations among complications. Several strong intcrre- 
latlons were noted among complications. Not surprkrn:ly. 
one of the strongest associations was between corer AI y 
occlusion and subsequent myocardia1 infarction (36% of 
patients with occlusion developed an infarction). Certasr! 
complications had a negative effect on outcome. Each acute 
coronary event, except for coronary dissection and branch 
vesi,ef occlu+n. was associated with increased mortality. 
Procedure-related ventricular fibrillation was associated 
with a very high subsequent in-hospital mortality rate of 
14%. The association of acute coronary complications with 
nonfatal myocardial infarction and with emergency coronary 
artery bypass grafting was also strking. 
Mortality. Mortality was low despite the presence of 
more extensive disease when compared with :he initial 
Registry experience. Baseline variables could be identified 
that were associated with increased in-hospital mortality. 
‘These included advanced age, female gender. severe coro- 
nary artery disease and poor left ventricular function. Other 
angiographic variables that are associated with increased 
ri\k include lesion calcification and the presence of intraco- 
ronary thrombus (20!, Identification of these variablts in 
patient5 currently undergoing angioplasty may a!low for 
more optjmal selection of dilation candidates as well as 
improved ri\k stratification for dilatron plannrng. 
Limitations of study. Several limitations of this study 
should be recognized. As a consequence of the study design. 
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only centers with long-fcrm angioplasly experience are in- 
cluded. However. the Registry sites do represent a consid- 
erable geographic diversity, as well as both large and small 
practices. Another consideration is that the transition begin- 
ning in 1983 from the fixed wire to the steerable guidewire 
dilation catheter coupled with subsequent balloon guidewire 
technotogic advances and increased operator experience 
allowed patients who would not have been considered 
candidates for angioplasty before 1983 lo undergo the pro- 
cedure in 1985 and 1986 (5-9). This change explains why the 
cohorts differ with respect lo the anatomy of attempted 
lesions. 
The data document that. as the patient population with 
more extensive disease was treated with angioplasty, the 
incidence of associated major complications did not increase 
and in some cases significantly decreased from that in the 
original cohort. Clearly. the more complex coronary anal- 
omy of these patients, the majority of whom had multiple 
sites of obstruction, did not preveni angioplasty from being 
highly successful with relatively low complication rates. 
Conclusions. Despite significant changes in patient selec- 
tion, coronary angioplasty as p’:rformed at the Registry sites 
during 1985 and 1986 demonstrated excellent success rates. 
Overall complication rates in the new cohort were either 
unchanged or decreased from the 1977-1981 rates despite a 
higher incidence of severe coronary artery disease and poor 
left ventricular function in these patients. The incidence of 
some complications. notably mortality, was higher in pa- 
tients with more severe vessel disease in the new cohort. 
When a major complirxtion did occur, it was often associ- 
ated with a poorer in ‘hospital outcome and prolonged hos- 
pilalization. 
These data support the concept that despite the excellenf 
overall results of percutaneous transluminal coronary angio- 
plasty in the ever-widening patient population, the proce- 
dure has an associated complication rate that is small but not 
negligible. This fact must be kept in mind when formulating 
optimal treatment strategies. 
Appendix 
The following persons and in3ti:utians participated in the National Heart. 
Lung. and Blood ln~iiruie Percu~ncous Tr&urninal Coronary Angioplasty 
Registry. 
Clinlul Centers 
Boston University Mediil Center/University Haspital, Etostan, MA. David 
P. Fanon. MD: Mirle A. Kelleti. MD: (former). Timothy Sanbom, MDi 
(former). Alice K. Jacobs. MD+ and Thomas Varricchionct: Emory Universlir 
Hospital, Allnnta, GA. (Because data from this center are currently being 
inlegrated into the new registry datl base. this sile was noI included in Ihe 
analysis.): Spncer B. King Ill. MD.* John Douglas. MD* and Cynthia 
Sututk Georgttow~ University Hospital, Wprhlngton, DC. Kenneth M. Kent. 
MD.* C.~rulyn Ewelsi. Katie ICehoe;: M~ch~tts General Hmpttal, Bos- 
tan, MA. Peter C. Block. MD* and EliLabelh Blockt: Mayo Clink, Raehester, 
MN. David R. Holmes. Jr.. MD.” Ronald E. Vlietstra. MD,? Guy S. Reeder, 
MD.t J. F. Hresnahan. MD.+ D. R. Brcsnahan. MD.+ A. A. Bove. MD+ 
Iformerl. Raymond J. Gibbons. MD.t R. A. Nishimura. MD.+ LaVon 
Hammcsf and Susy Brevigt: Mdlcal Center Hoapitat, HDustan, TX. Mehdi 
A~-B~wI~. MD* and Debbie LanceS; Medkal College of PennsylvanIa, 
Phltadelphla. PA. Lamberlo G. Benlivoglio. MS. MD* and Eileen Shappcll$: 
Medical Cdkgeof Virginia, Rkhmond, VA. Michael J. Cowley, MD,* George 
W. Vetrovec. MD.+ Stephen A. Lewis, MD.* German0 DiSciaqcio, MD1 and 
Kim KellyS: Mlamt Heart Instltuit. Mloml, FL. Arthur J. Gosselin. MD.’ Paul 
S. Swaye. MD.+ Paul A. Vignola, MD+ and Hazel Yon$; Montreal Heart 
Inslitutc, Monlnh, Quebec, Can&. Mania1 G. Bourassa. MD,* Paul RobcrI 
David, MD* (former). and Michclinc Labb&: Natkmal Heart, Lung. md 
Blood Idlult, B&K&, MD. Richard 0. Cannon. MD.* Martin Leon. MD* 
and Rila Mincemoyeti: Seton Me&at Center. Daly City. CA. Richard K. 
Myler. MD.* Simon H. Slertzer. MD.* David A. Clark. MD.* Mary Murphyl: 
and Jodi RosenS: RI&e Island Hospll*~rown Unlverslty, Providence. RI. 
David 0. Williams, MD* and Dana Mchdent: St. Framb Reglolul Me&at 
Center, Wkhita, KS, Joseph P. Galichia, MD* and Jan Me&$: St. Luke’s 
Epbcopal Hos#at. Housian, TX. Louis L. teatherman. MD,* Arthur J. 
Springer. MD+ and Joan Trivetlet: St. Luke’s Hospital, MlIwaukee, WI. 
Gerald Dorros. MD* and Lynne Janke-Maihiakt. 
Data Cmxdinatine Center 
University of-Plitsburgh, Plliskrgh. PA. Katherine M. D&e. MD. 
DrPhH.* Sheryl F. Kelsev. PhD.* John Wilson. PhD. Richard Hdubkov, 
MS. Ann Rodewald, MS and David Miller (statisticians): William Amoroso 
(manager. systems analysis): Sharon Caputo (programmer): Vema Niedcr- 
meyer (data manager): Poly Cole and Jayne Mona (research assistanls); and 
Denise Brooks (administrative secretary). NatlanaI Heart, Lung, and Bbad 
Instltule. &Ihcsda, MD. Eugene R. Passamani. MD and Thomas Robertson. 
MD {program office). 
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